Skip to main content
    A

    Amphastar P (AMPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $26.08
    +0.03 (+0.12%)

    Market Cap: $1.11B

    Last updated: Oct 16, 2026 at 1:54 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    77%(30/39)
    Avg Surprise
    +40.56%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.86
    Range$0.70 - $1.05
    7 analysts
    EPS Revisions
    1
    0
    7d
    5
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$0.83+4.6%
    60d ago$0.81+6.2%
    30d ago$0.79+9.2%
    7d ago$0.85+1.5%
    Current$0.86
    Revenue Consensus
    $198M
    Range$184M - $207M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.79
    Range$0.41 - $1.06
    7 analysts
    Revenue Consensus
    $197M
    Range$160M - $215M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.79---
    Sep 26EST
    		-$0.86---
    Jun 26
    Reported Aug 6
    		$0.80$0.51+56.86%Beat+6.7%
    Mar 26
    Reported May 7
    		$0.42$0.71-40.85%Miss-43.2%
    Dec 25
    Reported Feb 26
    		$0.61$0.89-31.46%Miss-33.7%
    Sep 25
    Reported Nov 6
    		$0.93$0.83+12.05%Beat-3.1%
    Jun 25
    Reported Aug 7
    		$0.75$0.64+17.19%Beat-20.2%
    Mar 25
    Reported May 7
    		$0.74$0.69+7.25%Beat-28.8%
    Dec 24
    Reported Feb 27
    		$0.92$0.94-1.95%Miss+4.5%
    Sep 24
    Reported Nov 6
    		$0.96$0.98-2.04%Miss-16.5%
    Jun 24
    Reported Aug 7
    		$0.94$0.75+25.33%Beat+44.6%
    Mar 24
    Reported May 8
    		$1.04$0.79+31.65%Beat+67.7%
    Dec 23
    Reported Feb 28
    		$0.88$0.91-3.30%Miss+20.5%
    Sep 23
    Reported Nov 8
    		$1.15$0.69+66.67%Beat+202.6%
    Jun 23
    Reported Aug 8
    		$0.65$0.56+16.07%Beat+66.7%
    Mar 23
    Reported May 9
    		$0.62$0.50+24.00%Beat+31.9%
    Dec 22
    Reported Feb 28
    		$0.73$0.41+78.05%Beat+73.8%
    Sep 22
    Reported Nov 7
    		$0.38$0.39-2.56%Miss-17.4%
    Jun 22
    Reported Aug 8
    		$0.39$0.35+11.43%Beat+85.7%
    Mar 22
    Reported May 9
    		$0.47$0.36+30.56%Beat+74.1%
    Dec 21
    Reported Mar 10
    		$0.42$0.36+16.67%Beat+162.5%
    Sep 21
    Reported Nov 8
    		$0.46$0.23+100.00%Beat+206.7%
    Jun 21
    Reported Aug 9
    		$0.21$0.21+0.00%Beat+31.2%
    Mar 21
    Reported May 6
    		$0.27$0.18+50.00%Beat+58.8%
    Dec 20
    Reported Mar 15
    		$0.16$0.14+14.29%Beat+128.6%
    Sep 20
    Reported Nov 6
    		$0.15$0.14+7.14%Beat+50.0%
    Jun 20
    Reported Aug 6
    		$0.16$0.14+14.29%Beat+100.0%
    Mar 20
    Reported May 7
    		$0.17$0.09+88.89%Beat+70.0%
    Dec 19
    Reported Mar 12
    		$0.07$0.08-12.50%Miss-46.2%
    Sep 19
    Reported Nov 7
    		$0.10$0.07+42.86%Beat-16.7%
    Jun 19
    Reported Aug 7
    		$0.08$0.05+60.00%Beat+166.7%
    Mar 19
    Reported May 9
    		$0.10$0.05+100.00%Beat+300.0%
    Dec 18
    Reported Mar 12
    		$0.13$0.11+18.18%Beat+30.0%
    Sep 18
    Reported Nov 8
    		$0.12$0.11+9.09%Beat+71.4%
    Jun 18
    Reported Aug 8
    		$0.03N/A-62.50%Miss-72.7%
    Mar 18
    Reported May 9
    		$-0.05$0.08-162.50%Miss-155.6%
    Dec 17
    Reported Mar 12
    		$0.10$-0.02+600.00%Beat+900.0%
    Sep 17
    Reported Nov 8
    		$0.07$0.03+133.33%Beat-
    Jun 17
    Reported Aug 9
    		$0.11$0.07+57.14%Beat-
    Mar 17
    Reported May 8
    		$0.09$0.08+12.50%Beat-
    Dec 16
    Reported Mar 13
    		$0.01$-0.01+200.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio9.45EV/EBITDA8.17x
    Price/FCF7.44xFCF Yield13.43%
    Profitability
    Profit Margin10.80%Operating Margin21.60%
    ROE10.30%ROIC6.63%
    Financial Health
    Debt/Equity0.80xInterest Coverage4.55x
    Current Ratio2.40xQuick Ratio1.71x
    Trading Statistics
    Beta0.90Avg Volume534.93K
    52-Week High$29.5252-Week Low$16.64

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$25.89
    SMA 20$25.62
    SMA 50$23.45
    SMA 200$22.33
    EMA 10$26.00
    EMA 20$25.48
    EMA 50$23.90
    EMA 200$22.67

    MACD

    Line: 0.79Signal: 0.88Hist: -0.09

    ADX

    ADX: 49.7+DI: 27.1-DI: 13.8

    Aroon & PSAR

    Aroon Up52.0
    Aroon DownN/A
    PSAR$25.14

    Bollinger Bands

    Upper Band$27.60
    Lower Band$23.64
    %B Position1546%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    59.2

    Momentum Oscillators

    Stoch %K51.2
    Stoch %D59.2
    Williams %R-62.1
    ROC (10d)1.0%
    Momentum0.27
    CCI (20d)52.0
    MFI (14d)48.4

    Volatility Measures

    ATR (14d)$0.88(3.4%)
    StdDev (20d)0.99
    Hist Vol38.9%(Moderate)

    Volume Flow

    VWAP$26.18
    OBV6.9M
    AD Line-4.2M
    CMF (20d)-0.074

    Volume Metrics

    Avg Vol (20d)545.5K
    Vol Ratio0.7x
    VWMA (20d)$25.46

    Pivot Points

    R3$27.66
    R2$27.33
    R1$26.69
    Pivot Point$26.36
    S1$25.72
    S2$25.39
    S3$24.75

    Advanced Oscillators

    TSI25.83
    Ultimate Osc51.5
    KST132.81

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$183.90M$171.17M$183.10M$191.84M$174.41M$170.53M$186.52M$191.21M$182.39M$171.84M$178.10M$180.56M
    Cost of Revenue$90.43M$100.85M$97.44M$93.19M$87.92M$85.28M$99.88M$89.27M$87.23M$81.74M$81.97M$72.15M
    Gross Profit$93.47M$70.32M$85.67M$98.65M$86.49M$85.25M$86.65M$101.94M$95.17M$90.10M$96.14M$108.40M
    Operating Expenses$53.74M$56.69M$50.06M$73.33M$44.31M$47.96M$41.50M$44.89M$39.95M$42.09M$42.16M$35.73M
    R&D$22.16M$26.74M$23.31M$22.35M$20.08M$20.10M$18.14M$21.08M$17.65M$17.04M$20.42M$16.66M
    SG&A$18.24M$18.03M$16.47M$39.47M$13.99M$16.00M$12.94M$14.82M$13.29M$15.68M$13.12M$12.65M
    Operating Income$39.73M$13.63M$35.61M$25.32M$42.18M$37.29M$45.14M$57.05M$55.22M$48.01M$53.98M$72.68M
    Interest Income$2.29M$2.40M$2.42M$2.25M$1.92M$2.09M$2.29M$2.43M$3.34M$2.56M$2.30M$1.20M
    Interest Expense$6.66M$6.55M$6.63M$6.28M$6.28M$6.29M$6.42M$6.70M$8.61M$8.61M$9.46M$13.70M
    Income Before Tax$38.54M$10.05M$31.91M$21.51M$39.34M$30.86M$43.96M$47.68M$50.24M$47.88M$41.34M$63.64M
    Income Tax Expense$8.20M$3.63M$7.49M$4.16M$8.30M$5.58M$6.00M$7.25M$12.29M$4.13M$4.67M$14.03M
    Net Income$30.35M$6.42M$24.43M$17.35M$31.03M$25.29M$37.96M$40.43M$37.95M$43.18M$36.17M$49.22M
    EBITDA$60.25M$31.46M$52.97M$42.20M$60.78M$51.03M$63.48M$67.13M$72.10M$70.02M$65.20M$94.94M
    EBIT$42.92M$14.21M$36.12M$25.55M$43.70M$35.06M$48.09M$51.95M$55.52M$53.93M$48.50M$76.14M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about AMPH

    News

    Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Crosses Above 50 Day Moving Average - Should You Sell?

    Amphastar Pharmaceuticals (AMPH) recently saw its share price rise above its 50-day moving average, reaching $26.86 compared to the average of $23.27. Despite beating quarterly earnings and revenue estimates...

    MarketBeat•10/13/26•Neutral

    Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts

    Argus has lowered its target price for Amphastar Pharmaceuticals Inc. (AMPH) to $27.00. The biopharmaceutical company, which specializes in generic and proprietary injectable, inhalation, and intranasal products...

    Yahoo! Finance Canada•10/7/26•Somewhat-Bearish

    Amphastar Pharmaceuticals Inc Share Price - AMPH, RNS News, Articles, Quotes, & Charts

    This article provides an overview of Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH), a specialty pharmaceutical company focused on injectable and inhalation products. It includes current market data...

    Proactive financial news•10/7/26•Somewhat-Bullish

    Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Rating Raised to Strong-Buy at Wall Street Zen

    Wall Street Zen has upgraded Amphastar Pharmaceuticals (NASDAQ:AMPH) to a "strong-buy" rating, despite a broader analyst consensus of "Reduce" with an average price target of $22.50. The company recently surpassed...

    MarketBeat•10/3/26•Somewhat-Bullish

    AMPH5896384 Bond Profile: Coupon and Redemption

    This article provides a detailed bond profile for AMPH5896384 issued by Amphastar Pharmaceuticals, Inc., featuring a 2.0% coupon rate and maturing on March 15...

    TradingView•10/1/26•Neutral

    AMPH Valuation and Fair Value

    P/E
    9.4x
    EV/EBITDA
    8.2x
    P/FCF
    7.4x
    PEG
    2.8x
    P/B
    1.5x
    See GNG's fair value

    AMPH Profitability: Margins, ROIC and FCF

    Gross margin
    47.7%
    Operating margin
    21.6%
    Net margin
    10.8%
    ROIC
    6.6%
    ROE
    10.3%
    FCF margin
    20.9%
    FCF yield
    13.4%

    AMPH Competitors

    CompanyTicker
    Tandem Diabetes Care IncTNDM
    STAAR Surgical CompanySTAA
    Omada Health, Inc. Common StockOMDA
    Teladoc IncTDOC
    Vor Biopharma IncVOR
    Procept Biorobotics CorpPRCT
    Taysha Gene Therapies IncTSHA
    Replimune Group IncREPL

    Sector: Healthcare

    AMPH Analyst Ratings

    Consensus
    Hold
    Analysts
    7
    Strong Buy
    0
    Buy
    0
    Hold
    6
    Sell
    0
    Strong Sell
    1

    AMPH Bull Case vs Bear Case

    Bull case

    • AMPH converts 20.9% of revenue into free cash flow.

    AMPH Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    2.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.86
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 2 down

    Frequently Asked Questions About AMPH

    Does AMPH pay dividends?

    Amphastar P (AMPH) does not currently pay a regular dividend.

    What is AMPH's P/E ratio?

    Amphastar P has a price-to-earnings (P/E) ratio of 9.45.

    What is AMPH's market cap?

    Amphastar P (AMPH) has a market capitalization of $1.11B with a current stock price of $26.08.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In